Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)

China · Delayed Price · Currency is CNY

38.50

+0.44 (1.16%)

Jun 2, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
In Vitro Diagnostic Test Paper	448.01M	559.40M	442.11M	1.90B	1.82B
In Vitro Diagnostic Test Paper Growth	-19.91%	26.53%	-76.75%	4.57%	110.09%
Total	448.01M	559.40M	442.11M	1.90B	1.82B
Total Growth	-19.91%	26.53%	-76.75%	4.57%	110.09%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	118.41M	-	-	-	-
Overseas	329.60M	-	-	-	-
Total	448.01M	-	-	-	-

Source: S&P Global Market Intelligence.